July 8 (Reuters) - UK's competition regulator said on
Monday it has cleared U.S. medical equipment maker Thermo Fisher
Scientific's ( TMO ) $3.1 billion deal to buy Swedish biotech
firm Olink Holding AB ( OLK ).